跳至主要内容
临床试验/ACTRN12622000866707
ACTRN12622000866707尚未招募未知

A randomised controlled trial to determine the impact of an artificial intelligence platform on adenoma detection rate during colonoscopy in adults

Waitakere Hospital0 个研究点目标入组 780 人开始时间: 2022年6月17日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
780

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Aged 18 years old or above;
  • They require elective colonoscopy for colorectal cancer screening, surveillance, or investigation of symptoms
  • Written informed consent obtained.

排除标准

  • Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, significant bleeding tendency, uninterrupted anticoagulation)
  • Scheduled staged procedure for polypectomy or biopsy
  • Inflammatory Bowel Disease
  • Previous bowel resection
  • Unable to obtain informed consent

研究者

发起方
Waitakere Hospital

相似试验